Cipla

Mumbai, India Founded: 1935 • Age: 91 yrs
APIs, generic drugs, and formulation services are manufactured.
Annual revenue $3.2B Latest available
Total funding - Funding intelligence
Employees 45190 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Cipla

Cipla is a company based in Mumbai (India) founded in 1935. The company has 45,190 employees as of March 31, 2024. Cipla has completed 9 acquisitions, including Avenue Therapeutics, Cipla Biotec and Cipla Medpro. Cipla offers products and services including Potatoes and Grain Marketing.

  • Headquarter Mumbai, India
  • Employees 45190 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Cipla Ltd
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $3.21 B (USD)
    6.74
    as on Mar 31, 2024
  • Net Profit
    $616 M (USD)
    27.93
    as on Mar 31, 2024
  • EBITDA
    $832.59 M (USD)
    12.05
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    45190

    as on Mar 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Cipla

Cipla is a publicly listed company on the NSE with ticker symbol CIPLA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: CIPLA · Sector: Health technology · India

Products & Services of Cipla

Cipla offers a comprehensive portfolio of products and services, including Potatoes and Grain Marketing.

Product name locked
Category locked
Primary

Potatoes are farmed and sold for food and industrial uses by the company

Product name locked
Category locked
Locked

Grains are promoted and distributed from farms by the company

People of Cipla

Headcount 10000+
Employee Profiles 398
Board Members and Advisors 9
Employee Profiles
People
Abhimanyu Singh
Regional Manager
People
Rahul Verma
Vice President Corporate Finance
People
Anurag Prasad
Senior Executive
People
Shreyal Bhandari
HR Associate (hrbp)

Unlock access to complete

Board Members and Advisors
people
Mandar Vaidya
Independent Director
people
Adil Zainulbhai
Non Executive Director
people
Sharmila Paranjpe
Independent Director
people
Abhijit Joshi
Non-Executive Director

Unlock access to complete

Funding Insights of Cipla

Premium access

Detailed funding history for Cipla

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cipla

Cipla has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Avenue Therapeutics, Cipla Biotec and Cipla Medpro.

Investments
Premium access

Investment portfolio details for Cipla

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Develops health products for nutritional balance and wellness promotion.
Locked Locked 2016 Locked
Formulation of tramadol HCI for the treatment of moderate to moderately severe post-operative pain.
Locked Locked 2015 Locked
Biscuits, wafers, noodles, coffee, and other snacks are manufactured.
Locked Locked 2011 Locked
Premium access

Complete acquisition details for Cipla

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Cipla

Premium access

Detailed financials for Cipla

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cipla Comparisons

Cipla Primary company
Description
APIs, generic drugs, and formulation services are manufactur...
Location
Mumbai, India
Founded Year
1935
Annual Revenue
$3.21 B (USD)
Net Profit
$616 M (USD)
EBITDA
$832.59 M (USD)
Employees
45,190
As of 2024
Premium access

Peer comparison for Cipla

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cipla

Premium access

Detailed competitors of Cipla

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cipla

Premium access

Complete news archive for Cipla

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cipla

Cipla was founded in 1935.

Cipla is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Umang Vohra is the current CEO of Cipla.

As of Mar 31, 2024, the latest employee count at Cipla is 45,190.

Annual revenue of Cipla is $3.21B as on Mar 31, 2024.

Founded in 1935 and headquartered in Mumbai, India, Cipla operates in the pharmaceutical sector. Active pharmaceutical ingredients, generic drugs, and formulation development services are produced. A broad portfolio covers therapeutic areas including allergy, cardiology, dermatology, diabetology, gastroenterology, HIV-AIDS, oncology, respiratory, and urology. Leadership is provided by CEO and Managing Director Umang Vohra. Operations focus on global distribution of these products.

Cipla offers Potatoes and Grain Marketing.

Yes, Cipla is publicly traded on NSE under the ticker symbol CIPLA.

Cipla has made 9 acquisitions, including Avenue Therapeutics, Cipla Biotec, and Cipla Medpro.

The ticker symbol of Cipla is CIPLA on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available